عفونت‌های ویروسی نوپدید و بازپدید به عنوان تهدید زیستی برای امنیت ملی و راهبردهای مدیریت و کنترل

1.    Baker RE, Mahmud AS, Miller IF, Rajeev M, Rasambainarivo F, Rice BL, et al. Infectious disease in an era of global change. Nature Reviews Microbiology. 2022;20(4):193-205. doi:10.1038/s4 1579-021-00639-z 
   2.    Bogoch II, Watts A, Thomas-Bachli A, Huber C, Kraemer MU, Khan K. Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel. Journal of Travel Medicine. 2020;27(2):taaa008. doi:10.1093/jtm/taaa008
   3.    McKibbin W, Fernando R. The global economic impacts of the COVID-19 pandemic. Economic Modelling. 2023;129:106551. doi:10.1016/j. econmod.2023.106551
   4.    Morens DM, Fauci AS. Emerging Pandemic Diseases: How We Got to COVID-19. Cell. 2020; 182(5):1077–92. doi:10.1016/j.cell.2020.08.021 
   5.    Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, et al. Global trends in emerging infectious diseases. Nature. 2008;451(7181):990–3. doi:10.1038/nature06536
   6.    Woolhouse ME, Gowtage-Sequeria S. Host range and emerging and reemerging pathogens. Emerging Infectious Diseases. 2005;11(12):1842–7. doi:10.3 201/eid1112.050997
   7.    Parums DV. A review of the resurgence of measles, a vaccine-preventable disease, as current concerns contrast with past hopes for measles elimination. Medical science monitor: international Medical Journal of Experimental and Clinical Research. 2024;30:e944436-1. doi:10.12659/MSM.944436
   8.    Segala FV, Guido G, Stroffolini G, Masini L, Cattaneo P, Moro L, et al. Insights into the ecological and climate crisis: Emerging infections threatening human health. Acta Tropica. 2025; 262:107531. doi:10.1016/j.actatropica.2025.107531
   9.    Heymann DL, Chen L, Takemi K, Fidler DP, Tappero JW, Thomas MJ, et al. Global health security: the wider lessons from the west African Ebola virus disease epidemic. Lancet. 2015;385 (9980):1884–901. doi:10.1016/s0140-6736(15)60858-3
   10.    Giangaspero M, Al Mahdhouri S, Al Bulushi S, Al-Ghafri MK, Turno P. Transboundary Diseases and One Health Approach Implications for Global Health Threats, with Particular Interest in Conservation and Bioterrorism. Pathogens. 2025; 14(12):1193.
   11.    Spernovasilis N, Tsiodras S, Poulakou G. Emerging and re-emerging infectious diseases: humankind’s companions and competitors. Microorganisms. 2022;10(1):98. doi:10.3390/microorganisms100100 98
   12.    Wang CC, Prather KA, Sznitman J, Jimenez JL, Lakdawala SS, Tufekci Z, et al. Airborne transmission of respiratory viruses. Science. 2021; 373(6558):eabd9149. doi:10.1097/mcp.00000000 00000947
   13.    Rojek A, Fieggen J, Apiyo P, Caluwaerts S, Fowler RA, Kaleebu P, et al. Ebola disease: bridging scientific discoveries and clinical application. The Lancet Infectious Diseases. 2025;25(3):e165–e76. doi:10.1016/S1473-3099(24)00673-X
   14.    Bavel JJ, Baicker K, Boggio PS, Capraro V, Cichocka A, Cikara M, et al. Using social and behavioural science to support COVID-19 pandemic response. Nature Human Behaviour. 2020;4(5):460-71. doi:10.1038/s41562-020-0884-z
   15.    Ijaz MK, Sattar SA, Nims RW, Boone SA, McKinney J, Gerba CP. Environmental dissemination of respiratory viruses: dynamic interdependencies of respiratory droplets, aerosols, aerial particulates, environmental surfaces, and contribution of viral re-aerosolization. PeerJ. 2023;11:e16420. doi:10.77 17/peerj.16420
   16.    Taylor S. The psychology of pandemics. Annual Review of Clinical Psychology. 2022;18(1):581-609. doi:10.1146/annurev-clinpsy-072720-020131
   17.    Iqbal G, Javed H, Raza FA, Gohar UF, Fatima W, Khurshid M. Diagnosis of Acute Dengue Virus Infection Using Enzyme‐Linked Immunosorbent Assay and Real‐Time PCR. Canadian Journal of Infectious Diseases and Medical Microbiology. 2023;2023(1):3995366. doi:10.1155/2023/3995366
   18.    Pauli G, Bauerfeind U, Blümel J, Burger R, Drosten C, Gröner A, et al. West nile virus. Transfusion Medicine and Hemotherapy. 2013;40(4):265-84. doi:10.1159/000353698
   19.    Sharmin S, Raj A, Zawad MA, Jahan A, Ahmed Z, Khair Fatema MU. Chapare Virus: A Re‐Emerging Zoonotic Arenavirus With Limited Preparedness. Reviews in Medical Virology. 2026;36(2):e70111. doi:10.1002/rmv.70111
   20.    Wang LF, Eaton BT. Bats, civets and the emergence of SARS. Wildlife and emerging zoonotic diseases: the biology, circumstances and consequences of cross-species transmission. 2007:325-44. doi:10.10 07/978-3-540-70962-6_13 
   21.    Lauxmann MA, Santucci NE, Autrán-Gómez AM. The SARS-CoV-2 coronavirus and the COVID-19 outbreak. International Brazilian Journal of Urology. 2020;46(Suppl 1):6-18. doi:10.1590/s1677-5538. ibju.2020.s101 
   22.    Mackay IM, Arden KE. MERS coronavirus: diagnostics, epidemiology and transmission. Virology Journal. 2015;12(1):222. doi:10.1186/s1 2985-015-0439-5
   23.    Uppala PK, Karanam SK, Kandra NV, Edhi S. Marburg virus disease: emerging threat, pathogenesis, and global public health strategies. World Journal of Virology. 2025;14(2):103576. doi:10.5501/wjv.v14.i2.103576

24.    Muyembe-Tamfum J-J, Mulangu S, Masumu J, Kayembe J, Kemp A, Paweska JT. Ebola virus outbreaks in Africa: past and present. Onderstepoort Journal of Veterinary Research. 2012;79(2):06–13. doi:10.4102/ojvr.v79i2.451
25.    Basinski AJ, Fichet-Calvet E, Sjodin AR, Varrelman TJ, Remien CH, Layman NC, et al. Bridging the gap: Using reservoir ecology and human serosurveys to estimate Lassa virus spillover in West Africa. PLoS Computational Biology. 2021;17(3):e1008811. doi:10.1371/journal.pcbi.1008811
26.    Kumar S, Subhadra S, Pal N, Pattnaik R, Gosh D. Challenges in diagnosis and control of Chikungunya virus infection: A review. Asian Pacific Journal of Tropical Medicine. 2025;18(10):431–42. doi:10.4103/apjtm.apjtm_525_25
27.    Spengler JR, Bergeron É, Spiropoulou CF. Crimean-Congo hemorrhagic fever and expansion from endemic regions. Current Opinion in Virology. 2019;34:70–8. doi:10.1016/j.coviro.2018.12.002
28.    Mansoor S, Maqbool I. Swine flu a seasonal pandemic, symptoms, diagnostics and prevention. Reviews and Research in Medical Microbiology. 2019;30(4):200–4. doi:10.1097/MRM.0000000000 000183
29.    Ferraz H, Akrami K, de Moraes L, Gusmão LC, Coelho G, Freitas D, et al. Screening semen samples for Zika virus infection: role for serologic and RT-PCR testing. Frontiers in Tropical Diseases. 2025;5:1489647. doi:10.3389/fitd.2024.1489647
30.    Amman BR, Albariño CG, Bird BH, Nyakarahuka L, Sealy TK, Balinandi S, et al. A recently discovered pathogenic paramyxovirus, Sosuga virus, is present in Rousettus aegyptiacus fruit bats at multiple locations in Uganda. The Journal of Wildlife Diseases. 2015;51(3):774–9. doi:10.7589/ 2015-02-044
31.    Yadav PD, Baid K, Patil DY, Shirin T, Rahman MZ, Peel AJ, Epstein JH, et al. A One Health approach to understanding and managing Nipah virus outbreaks. Nature Microbiology. 2025;10(6):1272-81. doi:10. 1038/s41564-025-02020-9 
32.    Li Y, Wang L, Chen S. An overview of the progress made in research into the Mpox virus. Medicinal Research Reviews. 2025;45(2):788-812. doi:10.10 02/med.22085
33.    Kivaria F, Mucheru G, Caudell M, Bebay C. Has the epidemiologic conundrum of Rift Valley fever changed?. Tropical Animal Health and Production. 2025;57(6):292. doi:10.1007/s11250-025-04531-3 
34.    Kamran M, Habib MB, Shahid A, Ahmar MA. Hantavirus: A Comprehensive Narrative Review of Virology, Epidemiology, Pathogenesis, Clinical Manifestations, Diagnostics, and Emerging Therapeutic Strategies. Reviews in Medical Virology. 2026; 36(4):e70190. doi:10.1002/rmv.70190
35.    Allen T, Murray KA, Zambrana-Torrelio C, Morse SS, Rondinini C, Di Marco M, et al. Global hotspots and correlates of emerging zoonotic diseases. Nature Communications. 2017;8(1):1124. doi:10.1038/ s41467-017-00923-8
36.    Carlson CJ, Albery GF, Merow C, Trisos CH, Zipfel CM, Eskew EA, et al. Climate change increases cross-species viral transmission risk. Nature. 2022;607(7919):555–62. doi:10.1038/s41586-022-04788-w 
37.    Neiderud CJ. How urbanization affects the epidemiology of emerging infectious diseases. Infection Ecology & Epidemiology. 2015;5(1): 27060. doi:10.3402/iee.v5.27060
38.    Guan D, Wang D, Hallegatte S, Davis SJ, Huo J, Li S, et al. Global supply-chain effects of COVID-19 control measures. Nature Human Behaviour. 2020;4(6):577–87. doi:10.1038/s41562-020-0896-8
39.    DiEuliis D, Giordano J. Why gene editors like CRISPR/Cas may be a game-changer for neuroweapons. Health Security. 2017;15(3):296-302. doi:10.1089/hs.2016.0120
40.    Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918-1920" Spanish" influenza pandemic. Bulletin of the History of Medicine. 2002;76(1):105-15. doi:10.1353/bhm. 2002.0022
41.    Heymann DL. The international response to the outbreak of SARS in 2003. Philosophical Transactions of the Royal Society B: Biological Sciences. 2004;359(1447):1127-9. doi:10.1098/rstb. 2004.1484
42.    Sachs JD, Karim SS, Aknin L, Allen J, Brosbøl K, Colombo F, et al. The Lancet Commission on lessons for the future from the COVID-19 pandemic. The Lancet. 2022;400(10359):1224-80. doi:10. 1016/s0140-6736(22)01585-9
43.    Meselson M, Guillemin J, Hugh-Jones M, Langmuir A, Popova I, Shelokov A, et al. The Sverdlovsk anthrax outbreak of 1979. Science. 1994; 266(5188):1202–8. doi:10.1126/science.7973702
44.    Jernigan DB, Raghunathan PL, Bell BP, Brechner R, Bresnitz EA, Butler JC, Cetron M, Cohen M, Doyle T, Fischer M, Greene C. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerging Infectious Diseases. 2002;8(10):1019. doi:10.3201/eid0810.020353
45.    Hassan N, Ali H, Hassan F, Ali H, Tawab A. Chapter 29 - Biosafety and biosecurity consideration in CRISPR-Cas. In: A Abd-Elsalam K, Ahmad A, Zhang B, editors. CRISPRized Horticulture Crops: Academic Press; 2024. pp. 507–20.

46.    Khalatbari-Soltani S, Cumming RC, Delpierre C, Kelly-Irving M. Importance of collecting data on socioeconomic determinants from the early stage of the COVID-19 outbreak onwards. Journal of Epidemiology and Community Health. 2020; 74(8):620-3. doi:10.1136/jech-2020-214297
47.    Payne DC, Smith-Jeffcoat SE, Nowak G, Chukwuma U, Geibe JR, Hawkins RJ, et al. SARS-CoV-2 infections and serologic responses from a sample of US Navy service members—USS Theodore Roosevelt, April 2020. MMWR. Morbidity and mortality weekly report. 2020; 69:714-21. doi:10.15585/mmwr.mm6923e4 
48.    Jin H, Xue J, Lin KL, Yang H, Zhu Z. Impact of supply chain disruptions on economic growth: Insights from a major public health crisis. INQUIRY: The Journal of Health Care Organization, Provision, and Financing. 2024;61: 00469580241266402.
49.    Klingsad R, Na Ayudhya BI. Impact of COVID-19 on Supply Chain Performance: A Case of Civil Railway Construction Projects. Procedia Computer Science. 2025;256:1445–50. doi:10.1016/j.procs. 2025.02.277
50.    Cullen W, Gulati G, Kelly BD. Mental health in the COVID-19 pandemic. QJM: An International Journal of Medicine. 2020;113(5):311-2. doi:10.10 56/NEJMp2008017
51.    Bollyky TJ, Bown CP. The tragedy of vaccine nationalism: only cooperation can end the pandemic. Foreign Aff.. 2020;99:96.
52.    Wang L, Lu D, Yang M, Chai S, Du H, Jiang H. Nipah virus: Epidemiology, pathogenesis, treatment, and prevention. Frontiers of Medicine. 2024; 18(6):969-87. doi:10.1007/s11684-024-1078-2 
53.    Moon S, Sridhar D, Pate MA, Jha AK, Clinton C, Delaunay S, et al. Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola. The Lancet. 2015; 386(10009):2204-21. doi:10.1016/S0140-6736(15) 00946-0 
54.    Patel MK, Goodson JL, Alexander Jr JP, Kretsinger K, Sodha SV, Steulet C, et al. Progress toward regional measles elimination—worldwide, 2000–2019. MMWR. Morbidity and Mortality Weekly Report. 2020;69:1700-5. doi:10.15585/mmwr. mm6945a6 
55.    Branda F, Giovanetti M, Petrosillo N, Ahmed MM, Perra M, Sanna D, et al. Measles and public health: An integrative approach. Biology Direct. 2025; 20(1):103. doi:10.1186/s13062-025-00693-0
56.    Wilder-Smith A, Gubler DJ, Weaver SC, Monath TP, Heymann DL, Scott TW. Epidemic arboviral diseases: priorities for research and public health. The Lancet Infectious Diseases. 2017;17(3):e101-6. doi:1016/s1473-3099(16)30518-7
57.    Hosseinian SA, Hajati MH. A comprehensive review of the zoonotic potential of avian influenza viruses: a globally circulating threat to pandemic influenza in human. Journal of Zoonotic Diseases. 2024;8(4):592–602. doi:10.22034/jzd.2024.18318
58.    Bijari M, Sadeghi-Sefidmazgi A, Ansari-Lari M, Ghaffari MH. Productivity, reproduction and economic losses due to foot-and-mouth disease (FMD) in Iranian Holstein cows. Preventive Veterinary Medicine. 2025;238:106471. doi:10.10 16/j.prevetmed.2025.106471
59.    Kitajima M, Ahmed W, Bibby K, Carducci A, Gerba CP, Hamilton KA, et al. SARS-CoV-2 in wastewater: State of the knowledge and research needs. Science of the Total Environment. 2020;7 39:139076. doi:10.1016/j.scitotenv.2020.139076
60.    Salimi-Jeda A, Abbassi S, Mousavizadeh A, Esghaie M, Bokharaei-Salim F, Jeddi F, et al. SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies. International Immunopharmacology. 2021;101:108232. doi:10.10 16/j.intimp.2021.108232
61.    Dao Thi VL, Herbst K, Boerner K, Meurer M, Kremer LP, Kirrmaier D, et al. A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samples. Science Translational Medicine. 2020;12(556):eabc7075. doi:10.1126/scitranslmed.abc7075
62.    Kellner MJ, Koob JG, Gootenberg JS, Abudayyeh OO, Zhang F. SHERLOCK: nucleic acid detection with CRISPR nucleases. Nature Protocols. 2019;14(10):2986-3012. doi:10.1038/s41596-019-0210-2 
63.    Seo G, Lee G, Kim MJ, Baek SH, Choi M, Ku KB, et al. Rapid detection of COVID-19 causative virus (SARS-CoV-2) in human nasopharyngeal swab specimens using field-effect transistor-based biosensor. ACS Nano. 2020;14(4):5135-42. doi:10.1021/acsnano.0c02823
64.    Verbeke R, Lentacker I, De Smedt SC, Dewitte H. The dawn of mRNA vaccines: The COVID-19 case. Journal of Controlled Release. 2021;333:511-20. doi:10.1016/j.jconrel.2021.03.043
65.    Corbett KS, Edwards DK, Leist SR, Abiona OM, Boyoglu-Barnum S, Gillespie RA, et al. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature. 2020;586(7830): 567–71. doi:10.1038/s41586-020-2622-0
66.    Pantaleo G, Correia B, Fenwick C, Joo VS, Perez L. Antibodies to combat viral infections: development strategies and progress. Nature Reviews Drug Discovery. 2022;21(9):676–96. doi:10.1038/s 41573-022-00495-3

67.    Esposito S, Amirthalingam G, Bassetti M, Blasi F, De Rosa FG, Halasa NB, et al. Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy. Frontiers in Immunology. 2023;14:1162342. doi:10.3389/fimmu.2023.1162342
68.    Destoumieux-Garzón D, Mavingui P, Boetsch G, Boissier J, Darriet F, Duboz P, et al. The one health concept: 10 years old and a long road ahead. Frontiers in Veterinary Science. 2018;5:14. doi:10.3389/fvets.2018.00014
69.    Karesh WB, Dobson A, Lloyd-Smith JO, Lubroth J, Dixon MA, Bennett M, et al. Ecology of zoonoses: natural and unnatural histories. Lancet. 2012;380 (9857):1936–45. doi:10.1016/s0140-6736(12)61678-x
70.    Jin A, Linkov I. Synthetic biology brings new challenges to managing biosecurity and biosafety. Emerging Threats of Synthetic Biology and Biotechnology: Addressing Security and Resilience Issues. 2021:117-29.
71.    Aldis W. Health security as a public health concept: a critical analysis. Health Policy and Planning. 2008;23(6):369-75. doi:10.1093/heapol/czn030
72.    Bardosh KL, de Vries DH, Abramowitz S, Thorlie A, Cremers L, Kinsman J, et al. Integrating the social sciences in epidemic preparedness and response: a strategic framework to strengthen capacities and improve global health security. Globalization and Health. 2020;16(1):120. doi:10.1186/s12992-020-00652-6 
73.    Trump BD FM, Perkins E, Linkov I, editors., Emerging threats of synthetic biology and biotechnology: addressing security and resilience issues.: Springer; 2021. doi:10.1007/978-94-024-2086-9
74.    Okon MB, Ugwu OP, Ugwu CN, Ogenyi FC, Swase DT, Anyanwu CN, et al. From pandemics to preparedness: harnessing AI, CRISPR, and synthetic biology to counter biosecurity threats. Frontiers in Public Health. 2025;13:1711344. doi:10.3389/fpubh.2025.1711344
75.    Cropper NR, Rath S, Teo RJ, Warmbrod KL, Lancaster MJ. A modular-incremental approach to improving compliance verification with the biological weapons convention. Health Security. 2023;21(5):421-7. doi:10.1089/hs.2023.0078
76.    Dzau VJ, Halton J, Kaseya J, Oramah B, Røttingen JA, Lucera M, et al. Closing the deal: a G20 panel report on financing for pandemic threats. The Lancet. 2025;406(10517):2296-8. doi:10.1016/S01 40-6736(25)02275-5 
77.    Van der Linden S, Maibach E, Cook J, Leiserowitz A, Lewandowsky S. Inoculating against misinformation. Science. 2017;358(6367):1141-2. doi:10.1126/science.aar4533